New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
Authors:
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 79, 1-38
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Matrix MetalloproteinasesDrugs & Aging, 1997
- PDGF-BB increases endothelial migration and cord movements during angiogenesis in vitroJournal of Cellular Biochemistry, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancerSurgical Oncology, 1996
- Expression of Fibroblast Growth Factor Gene Family and Its Receptor Gene Family in the Human Upper Gastrointestinal TractBiochemical and Biophysical Research Communications, 1994
- Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasionThe Prostate, 1994
- Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor ?Journal of Cancer Research and Clinical Oncology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987